Reduced Toxicity Conditioning With Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children With High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD

Biology of Blood and Marrow Transplantation - Netherlands

doi 10.1016/j.bbmt.2012.11.132